1982. The Tylenol case
In the autumn of 1982, seven people in the Chicago area died after taking Extra-Strength Tylenol capsules that had been laced with potassium cyanide. Johnson & Johnson pulled the product nationally, warned the public not to take it, and reintroduced it in tamper-evident packaging. It remains the reference case in crisis communications, and it is routinely misread.
What happened
The deaths occurred over a short period and were linked to capsules bought from several different shops. The contamination had happened after the product left the company, which is to say Johnson & Johnson had not caused it and could not have prevented it through any manufacturing control.
The company nonetheless withdrew the product from the entire United States market, not from Chicago, and told consumers publicly not to take Tylenol until it was resolved. The withdrawal was enormous and the cost was substantial.
Tylenol returned to the market in new packaging with a tamper-evident seal, a format that became standard across the industry and was subsequently reinforced by federal regulation.
The person responsible was never identified. The case is open.
Why it became the reference case
Because the company acted against its own immediate commercial interest, visibly, before it was required to.
The decision that gets taught is the national recall. The narrow commercial logic pointed to a Chicago recall: the problem was geographically contained, the company was not at fault, and a national withdrawal destroyed an enormous amount of inventory and revenue. They did it anyway.
That is the whole lesson, and it is a lesson about decision rights and standing commitments rather than about communications. The company had a credo, written decades earlier, that put patients and users first and shareholders last in order. Whether that document caused the decision or merely described a culture that would have made it anyway is not something the record settles.
What people get wrong about it
They read it as a public relations success. It was an operating decision with a communications consequence. The withdrawal was the act. The press conferences reported it. Reversing that order is how companies end up believing a crisis is a messaging problem.
They assume the recovery was immediate. Market share fell sharply and recovery took time and substantial investment, including the packaging redesign, a coupon programme and heavy advertising. The story as usually told compresses a long and expensive year into a paragraph.
They treat it as a template. The circumstances were unusual in a way that matters: the company was not at fault. Most corporate crises are the opposite, and the hardest part is acknowledging fault rather than demonstrating care about someone else’s. A playbook drawn from Tylenol will not survive contact with a crisis you caused.
They forget the second one. There was a further tampering incident in 1986, after which the company stopped selling capsules altogether and moved to caplets. The second decision is arguably the more instructive, because by then the cost was known and they did it again.
What transfers
Three things, and only three.
The decision has to be made before the crisis, in the form of a standing rule about what you will not trade away. Decided in the moment, under cost pressure, almost nobody chooses the expensive option.
Speed matters more than completeness. They acted while facts were still unknown, which is the opposite of most legal advice.
And the response has to cost you something visible, or it does not register as sincere. An action that is free reads as public relations, because it is.
What to do with it
- Write down now, before anything happens, the one or two things you will not trade for revenue. Specific, not values language.
- Decide who can order a withdrawal or a stop, and at what cost ceiling, without convening anybody. If that person does not exist, you do not have a crisis plan.
- Separate the operating decision from the communications about it, in your own planning. Confusing them is the standard failure.
- Assume you will be at fault. Build the plan for that case, because Tylenol’s case is the rare one.
- Budget for a slow recovery. Share returned; it did not spring back.
If you run the company rather than the marketing
The reason this case is taught to executives rather than to communications teams is that the decision in it was not available to a communications team.
Somebody had to authorise destroying an enormous quantity of saleable product, quickly, on incomplete information, for a problem the company had not caused. No head of communications can make that call, and by the time it reaches a committee the moment has passed.
So the question this case puts to you is narrow and uncomfortable. If something goes seriously wrong on a Friday, who in your company can stop the thing happening, at what cost, without asking anyone? If the answer is nobody, then your crisis plan is a document about messaging and it will not help you.
The second question is what your standing commitments actually are, as opposed to what your values page says. Tylenol’s credo was decades old and ranked shareholders last. That ranking was written down before it was expensive.
Sources
- Contemporaneous reporting and Johnson & Johnson's own published account of the 1982 and 1986 incidents. Specific figures for market share loss and recall cost vary considerably between retellings and should be taken from a primary source rather than from a case-study summary.
Every source cited across the Hive is listed in the Library.